Oncolytic and Immunotherapeutic Vaccinia Induces Antibody-Mediated Complement-Dependent Cancer Cell Lysis in Humans
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncolytic and Immunotherapeutic Vaccinia Induces Antibody-Mediated Complement-Dependent Cancer Cell Lysis in Humans
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 5, Issue 185, Pages 185ra63-185ra63
Publisher
American Association for the Advancement of Science (AAAS)
Online
2013-05-16
DOI
10.1126/scitranslmed.3005361
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gene Deletions and Amplifications in Human Hepatocellular Carcinomas
- (2012) Michael A. Nalesnik et al. AMERICAN JOURNAL OF PATHOLOGY
- Intracellular Tumor-Associated Antigens Represent Effective Targets for Passive Immunotherapy
- (2012) T. Noguchi et al. CANCER RESEARCH
- Ofatumumab Is More Efficient than Rituximab in Lysing B Chronic Lymphocytic Leukemia Cells in Whole Blood and in Combination with Chemotherapy
- (2012) L. Bologna et al. JOURNAL OF IMMUNOLOGY
- Modified Model of VX2 Tumor Overexpressing Vascular Endothelial Growth Factor
- (2012) Florentina Pascale et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators
- (2012) Akihiro Fujimoto et al. NATURE GENETICS
- Ofatumumab is active in patients with fludarabine-refractory CLL irrespective of prior rituximab: results from the phase 2 international study
- (2011) W. G. Wierda et al. BLOOD
- rILYd4, a Human CD59 Inhibitor, Enhances Complement-Dependent Cytotoxicity of Ofatumumab against Rituximab-Resistant B-cell Lymphoma Cells and Chronic Lymphocytic Leukemia
- (2011) X. Ge et al. CLINICAL CANCER RESEARCH
- Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans
- (2011) Caroline J. Breitbach et al. NATURE
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinoma
- (2010) J. M. Howard et al. BRITISH JOURNAL OF SURGERY
- Hypoxia-inducible adenosine A2B receptor modulates proliferation of colon carcinoma cells
- (2010) De-Fu Ma et al. HUMAN PATHOLOGY
- More than Markers: Biological Significance of Cancer Stem Cell-Defining Molecules
- (2010) S. B. Keysar et al. MOLECULAR CANCER THERAPEUTICS
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Toll-like receptor 8-mediated activation of murine plasmacytoid dendritic cells by vaccinia viral DNA
- (2010) J. Martinez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
- (2009) Howard L. Kaufman et al. ANNALS OF SURGICAL ONCOLOGY
- Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer
- (2009) Celestia S. Higano et al. CANCER
- Oncolytic and immunostimulatory efficacy of a targeted oncolytic poxvirus expressing human GM-CSF following intravenous administration in a rabbit tumor model
- (2009) J-H Lee et al. CANCER GENE THERAPY
- Identification of tumor-associated antigens by using SEREX in hepatocellular carcinoma
- (2009) Kaijuan Wang et al. CANCER LETTERS
- CD24 Is a Novel Predictor for Poor Prognosis of Hepatocellular Carcinoma after Surgery
- (2009) X.-R. Yang et al. CLINICAL CANCER RESEARCH
- Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication
- (2009) R. J. Prestwich et al. CLINICAL CANCER RESEARCH
- Enhancing Poxvirus Oncolytic Effects through Increased Spread and Immune Evasion
- (2008) D. H. Kirn et al. CANCER RESEARCH
- Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic Carcinoma
- (2008) J. L. Gulley et al. CLINICAL CANCER RESEARCH
- A Polymorphism in the Complement Component C1qA Correlates with Prolonged Response Following Rituximab Therapy of Follicular Lymphoma
- (2008) E. Racila et al. CLINICAL CANCER RESEARCH
- Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial
- (2008) Byeong-Ho Park et al. LANCET ONCOLOGY
- Translation of Targeted Oncolytic Virotherapeutics from the Lab into the Clinic, and Back Again: A High-Value Iterative Loop
- (2008) Ta-Chiang Liu et al. MOLECULAR THERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started